Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives

COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged in Wuhan, China, and has spread worldwide, resulting in over 73 million cases and more than 1 600 000 deaths as of December 2020. Although the disease is asympto...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Antimicrob Agents
Prif Awduron: Memish, Ziad A., Faqihi, Fahad, Alharthy, Abdulrahman, Alqahtani, Saleh A., Karakitsos, Dimitrios
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Pynciau:
Short Communication
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834644/
https://ncbi.nlm.nih.gov/pubmed/33370568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106273
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg